Mark Corrigan - Jun 2, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Director
Signature
/s/ Robert Crotty, by power of attorney
Stock symbol
NBRV
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 05:50 PM
Next filing
Jul 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Options Award $0 +10.5K $0.00 10.5K Jun 2, 2021 Ordinary Shares 10.5K $1.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 2, 2021.
F2 The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer.